← brief for 2026-09-07 · Slowing decline

Beyond Genotype: Proteomic Risk Stratification for APOL1-Mediated Kidney Disease

Key takeaways

This is an expert opinion piece in a kidney journal, not a new study. It comments on other researchers' work that used proteins measured in the blood to predict who will get worse kidney disease among people carrying two high-risk copies of the APOL1 gene, a gene change that raises kidney risk and is most common in people of West African ancestry. The point being made is that the gene test alone does not tell you who will decline, so a blood protein score might narrow it down. The commentary itself reports no new data, so there is nothing here to act on yet.

Source

Paper · AJKD · 2026-09-07
https://www.ajkd.org/article/S0272-6386(26)01092-9/fulltext?rss=yes